Marinus Pharmaceuticals (NASDAQ:MRNS) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note published on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Price Performance NASDAQ:MRNS opened at $0.55 on Wednesday. The company’s 50-day moving average is $0.55 and its two-hundred day moving average is $0.73. […]
StockNews.com initiated coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note published on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Price Performance NASDAQ:MRNS opened at $0.55 on Wednesday. The company’s 50-day moving average is $0.55 and its two-hundred day moving average is $0.73. […]
